Published in Hepatology on July 01, 1999
Redox regulation of cell survival. Antioxid Redox Signal (2008) 4.33
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest (2009) 1.75
Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci U S A (2005) 1.57
Glutathione and apoptosis. Free Radic Res (2008) 1.48
Metabolic control of T cell activation and death in SLE. Autoimmun Rev (2008) 1.28
Cyanobacterial lipopolysaccharides and human health - a review. Environ Health (2006) 1.12
Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis. J Exp Med (2000) 1.11
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med (2011) 1.06
Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis. Biochem J (2001) 0.93
Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells. World J Gastroenterol (2009) 0.87
Zinc deficiency mediates alcohol-induced apoptotic cell death in the liver of rats through activating ER and mitochondrial cell death pathways. Am J Physiol Gastrointest Liver Physiol (2015) 0.87
Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice. Am J Pathol (2000) 0.81
A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest (1992) 4.39
Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol (1994) 2.87
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol (1995) 2.55
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther (1999) 2.33
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology (1996) 2.27
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med (2000) 2.19
Glutathione peroxidase. Methods Enzymol (1981) 2.07
The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. Eur J Biochem (1983) 2.05
Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo. Acta Anaesthesiol Scand (2008) 2.04
The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell (2000) 1.96
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol (1989) 1.87
Alteration of monocyte function following major injury. Arch Surg (1988) 1.64
Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock (1996) 1.63
Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol (1992) 1.60
Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood (1997) 1.58
In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol (1997) 1.53
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood (1995) 1.52
Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol (1991) 1.52
The fate of extracellular glutathione in the rat. Biochim Biophys Acta (1978) 1.45
Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol (1995) 1.45
Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun (2001) 1.40
Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma (2000) 1.40
Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock (1992) 1.36
Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med (1998) 1.36
A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol (1984) 1.34
In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br J Pharmacol (1997) 1.34
The amino-acid sequence of bovine glutathione peroxidase. Hoppe Seylers Z Physiol Chem (1984) 1.31
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30
Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma (1997) 1.28
Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol (1997) 1.26
Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun (1997) 1.25
The gut: a cytokine-generating organ in systemic inflammation? Shock (1995) 1.25
The level and half-life of glutathione in human plasma. FEBS Lett (1980) 1.21
Posterior elbow dislocation with associated vascular injury after blunt trauma. J Trauma (1999) 1.20
Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. Biochem Pharmacol (1979) 1.20
Hemorrhage and resuscitation: immunological aspects. Am J Physiol (1990) 1.20
Selenium and drug metabolism--I. Multiple modulations of mouse liver enzymes. Biochem Pharmacol (1983) 1.18
The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med (1996) 1.16
Drug-induced lipid peroxidation in mice--I. Modulation by monooxygenase activity, glutathione and selenium status. Biochem Pharmacol (1981) 1.15
Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol (1995) 1.13
Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood (2000) 1.13
Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock (1996) 1.11
[Glutathion peroxidase. I. Isolation and determinations of molecular weight]. Hoppe Seylers Z Physiol Chem (1971) 1.11
Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis. J Exp Med (2000) 1.11
Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J Immunol (1991) 1.11
DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol (1996) 1.10
Differential effect of anti-TNF-alpha antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion. Shock (1999) 1.08
Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine (1992) 1.07
[Management of spine injuries in polytraumatized patients]. Orthopade (2005) 1.06
Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology (1997) 1.05
Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology (1999) 1.05
Structure analysis and molecular model of the selenoenzyme glutathione peroxidase at 2.8 A resolution. J Mol Biol (1979) 1.04
Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma (1996) 1.04
Leukotriene-mediated liver injury. Biochem Pharmacol (1988) 1.03
Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. J Biol Chem (1993) 1.03
Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol Med (1997) 1.03
Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Physiol (1998) 1.03
The role of pro-inflammatory and immunoregulatory cytokines in tendon healing and rupture: new insights. Scand J Med Sci Sports (2011) 1.03
Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice. Biochem Pharmacol (1990) 1.02
ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett (1997) 1.01
Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis (1996) 1.00
Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock (2001) 1.00
Selenium and drug metabolism--III. Relation of glutathione-peroxidase and other hepatic enzyme modulations to dietary supplements. Biochem Pharmacol (1985) 1.00
Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. Biochim Biophys Acta (1990) 1.00
[Current concepts of polytrauma management: from ATLS to "damage control"]. Orthopade (2005) 1.00
The expression of plasma membrane Ca2+ pump isoforms in cerebellar granule neurons is modulated by Ca2+. J Biol Chem (1999) 0.99
The physiological consequences of glutathione variations. Life Sci (1992) 0.99
In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol (1997) 0.98
Selenium and drug metabolism--II. Independence of glutathione peroxidase and reversibility of hepatic enzyme modulations in deficient mice. Biochem Pharmacol (1984) 0.98
Immunologic monitoring of heart transplant patients under cyclosporine immunosuppression. Transplant Proc (1984) 0.97
Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol (1999) 0.97
Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol (1997) 0.96
1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Mol Pharmacol (1998) 0.96
Drug-induced lipid peroxidation in mice--II. Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione. Biochem Pharmacol (1982) 0.96
Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma (1990) 0.95
Diltiazem restores IL-2, IL-3, IL-6, and IFN-gamma synthesis and decreases host susceptibility to sepsis following hemorrhage. J Surg Res (1991) 0.95
Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun (1999) 0.95
Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect Immun (2001) 0.95
Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest (1994) 0.95
Hydrocarbon exhalation. Methods Enzymol (1981) 0.94
Substrate-induced redox change of selenium in glutathione peroxidase studied by x-ray photoelectron spectroscopy. Biochim Biophys Acta (1975) 0.94
Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes. Clin Exp Allergy (1995) 0.94
The activity of the peroxide-metabolizing system in human colon carcinoma. J Cancer Res Clin Oncol (1980) 0.94
Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods. European Centre for the Validation of Alternative Methods. Altern Lab Anim (2001) 0.94
Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages. Clin Exp Allergy (1995) 0.94
Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J (1999) 0.94
Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery (1992) 0.93
Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol (1995) 0.92
Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation. Br J Pharmacol (1998) 0.92
Temporal sequence of pulmonary and systemic inflammatory responses to graded polymicrobial peritonitis in mice. Infect Immun (1999) 0.91
A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol (1985) 0.91
Cytoimmunological monitoring in acute rejection and viral, bacterial or fungal infection following transplantation. J Heart Transplant (1987) 0.91
Ethane production by isolated perfused rat liver: a system to study metabolic effects related to lipid peroxidation. FEBS Lett (1981) 0.91
Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med (1998) 0.91
Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients. Acta Haematol (1996) 0.91
Interleukin-10 modulates pro-apoptotic effects of TNF-alpha in human articular chondrocytes in vitro. Cytokine (2007) 0.90